217.950 License for manufacture of laetrile -- Regulations -- Use in health care facilities licensed by cabinet. (1) Amygdalin (laetrile) may be manufactured in this state subject to licensing and regulation by the Cabinet for Health and Family Services. The secretary of the <br>cabinet shall adopt regulations which prescribe minimum standards for <br>manufacturers in preparing, compounding, processing, and packaging the substance. <br>The secretary shall establish standards of purity and shall make periodic tests and <br>inspections of both the facilities for manufacture and samples of the substance to <br>ascertain the purity, quality, and identity of the substance and to determine that the <br>substance meets the standards so established. (2) The Cabinet for Health and Family Services shall make no rule or regulation which would prohibit the use of amygdalin (laetrile) in any hospital, ambulatory outpatient <br>surgical center, or health-care facility licensed by it. Effective: June 20, 2005 <br>History: Amended 2005 Ky. Acts ch. 99, sec. 522, effective June 20, 2005. -- Amended 1998 Ky. Acts ch. 426, sec. 466, effective July 15, 1998. -- Created 1980 Ky. Acts <br>ch. 354, sec. 7, effective July 15, 1980.
217.950 License for manufacture of laetrile -- Regulations -- Use in health care facilities licensed by cabinet. (1) Amygdalin (laetrile) may be manufactured in this state subject to licensing and regulation by the Cabinet for Health and Family Services. The secretary of the <br>cabinet shall adopt regulations which prescribe minimum standards for <br>manufacturers in preparing, compounding, processing, and packaging the substance. <br>The secretary shall establish standards of purity and shall make periodic tests and <br>inspections of both the facilities for manufacture and samples of the substance to <br>ascertain the purity, quality, and identity of the substance and to determine that the <br>substance meets the standards so established. (2) The Cabinet for Health and Family Services shall make no rule or regulation which would prohibit the use of amygdalin (laetrile) in any hospital, ambulatory outpatient <br>surgical center, or health-care facility licensed by it. Effective: June 20, 2005 <br>History: Amended 2005 Ky. Acts ch. 99, sec. 522, effective June 20, 2005. -- Amended 1998 Ky. Acts ch. 426, sec. 466, effective July 15, 1998. -- Created 1980 Ky. Acts <br>ch. 354, sec. 7, effective July 15, 1980.
217.950 License for manufacture of laetrile -- Regulations -- Use in health care facilities licensed by cabinet. (1) Amygdalin (laetrile) may be manufactured in this state subject to licensing and regulation by the Cabinet for Health and Family Services. The secretary of the <br>cabinet shall adopt regulations which prescribe minimum standards for <br>manufacturers in preparing, compounding, processing, and packaging the substance. <br>The secretary shall establish standards of purity and shall make periodic tests and <br>inspections of both the facilities for manufacture and samples of the substance to <br>ascertain the purity, quality, and identity of the substance and to determine that the <br>substance meets the standards so established. (2) The Cabinet for Health and Family Services shall make no rule or regulation which would prohibit the use of amygdalin (laetrile) in any hospital, ambulatory outpatient <br>surgical center, or health-care facility licensed by it. Effective: June 20, 2005 <br>History: Amended 2005 Ky. Acts ch. 99, sec. 522, effective June 20, 2005. -- Amended 1998 Ky. Acts ch. 426, sec. 466, effective July 15, 1998. -- Created 1980 Ky. Acts <br>ch. 354, sec. 7, effective July 15, 1980.
